Mu and colleagues discovered that inhibiting DDR2 lowers inflammation and joint destruction via the H19-miR-103a-IL-15/Dkk-1 axis, where DDR2 plays a stimulatory function in the development of RA. The gene discussed is IL15; the disease is rheumatoid arthritis.